Literature DB >> 24844656

How much do we really know about statins and transplant vasculopathy?

Alden H Harken1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24844656     DOI： 10.1007/s00268-014-2623-y

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

Review 1.  The discovery and development of HMG-CoA reductase inhibitors.

Authors:  A Endo
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

Review 2.  Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

Authors:  Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; Sebhat Erqou; Peter Sever; J Wouter Jukema; Ian Ford; Naveed Sattar
Journal:  Arch Intern Med       Date:  2010-06-28

Review 3.  Allograft vasculopathy versus atherosclerosis.

Authors:  Maziar Rahmani; Rani P Cruz; David J Granville; Bruce M McManus
Journal:  Circ Res       Date:  2006-10-13       Impact factor: 17.367

Review 4.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

Review 5.  Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.

Authors:  Robin Som; Peter J Morris; Simon R Knight
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.